Reagent Set for Quantitative Determination of 17α-Hydroxyprogesterone in Human Serum or Plasma Using Immunoenzymatic Analysis "IFА-17-ОН-ПГ" According to TU 9398-018-17253567-2006

The "IFА-17-ОН-ПГ" reagent set is designed for the quantitative determination of 17α-hydroxyprogesterone in human serum or plasma using immunoenzymatic analysis (ELISA), in accordance with TU 9398-018-17253567-2006.

Reagent Set Components:

96-Well Plate: Polystyrene, with immobilized mouse monoclonal IgG antibodies to 17α-OH-PG human on the inner surface of the wells – 1 unit.
Calibration Samples: Human serum-based samples containing known amounts of 17α-OH-PG, as follows:
- 0 ng/mL (1.0 ml)
- 0.2 ng/mL (0.8 ml)
- 0.4 ng/mL (0.8 ml)
- 1.6 ng/mL (0.8 ml)
- 6.4 ng/mL (0.8 ml)
- 19.2 ng/mL (0.8 ml)
Conjugate: 17α-OH-PG conjugated with horseradish peroxidase – 1 vial (6.0 ml).
TMБ Solution: 11x concentrated – 1 tube (1.5 ml).
Control Serum: Human serum with a known content of 17α-OH-PG – 1 tube (0.6 ml).
Wash Solution: 20x concentrated – 1 bottle (50 ml).
Substrate Buffer: 1 bottle (15 ml).
Stop Reagent: 1 bottle (15 ml).

Choose the "IFА-17-ОН-ПГ" reagent set for precise and quantitative determination of 17α-hydroxyprogesterone in human biological samples.

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Set for Quantitative Determination of 17α-Hydroxyprogesterone in Human Serum or Plasma Using Immunoenzymatic Analysis "IFА-17-ОН-ПГ" According to TU 9398-018-17253567-2006, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.

Back